MassIVE MSV000086457

Partial Public

Targeted degradation of the enhancer lysine acetyltransferases CBP and p300

Description

The enhancer factors CBP/p300 maintain gene expression programs through lysine acetylation of chromatin and transcriptional regulators and by scaffolding functions mediated by several protein-protein interaction domains. We have designed dCBP-1, a compound that induces degradation of CBP/p300, and profiled its activity inducing global proteome changes in HAP1 and MM1S cells. The proteome changes were mapped using multiplexed quantitative proteomics (TMT11) and applying the SPS-MS3 method on either an Orbitrap Fusion or an Orbitrap Lumos Fusion mass spectrometer. The proteome was mapped 3 hours and 6 hours upon drug treatment. Samples were covered over two TMT sets for both time points. Samples for the 3 hours time points (HAP1 and MM1S) were analyzed using a total of 48 fractions on an Orbitrap Lumos mass spectrometer. Samples for the 6 hours time point (MM1S) were analyzed using a total of 20 fractions on an Orbitrap Fusion mass spectrometer. Samples were analyzed in three replicates (rep1-rep3). Pooled tryptic digests were used as bridge channels to compare proteome profiles from the two TMT sets mapped per time point. Samples were labeled as described in the following: 3 hours: HAP1_DMSO_3h_rep1 (Ott_3hours_TMT1_129c); HAP1_DMSO_3h_rep2 (Ott_3hours_TMT1_130n); HAP1_DMSO_3h_rep3 (Ott_3hours_TMT1_130c); HAP1_dCBP1_3h_rep1 (Ott_3hours_TMT2_129c); HAP1_dCBP1_3h_rep2 (Ott_3hours_TMT2_130n); HAP1_dCBP1_3h_rep3 (Ott_3hours_TMT2_130c); MM1S_DMSO_3h_rep1 (Ott_3hours_TMT1_126); MM1S_DMSO_3h_rep2 (Ott_3hours_TMT1_127n); MM1S_DMSO_3h_rep3 (Ott_3hours_TMT1_127c); MM1S_dCBP1_3h_rep1 (Ott_3hours_TMT1_128n); MM1S_dCBP1_3h_rep2 (Ott_3hours_TMT1_128c); MM1S_dCBP1_3h_rep3 (Ott_3hours_TMT1_129n); Bridge channels (Ott_3hours_TMT1 and TMT2, 131n). 6 hours: TMT1_128c (Ott_6hours_TMT1_128c); TMT2_126 (Ott_6hours_TMT2_126); TMT2_129c (Ott_6hours_TMT2_129c); TMT1_129n (Ott_6hours_TMT1_129n); TMT2_127n (Ott_6hours_TMT2_127n); TMT2_130n (Ott_6hours_TMT2_130n); Bridge channels (Ott_6hours_TMT1 and TMT2, 131c). [doi:10.25345/C53F66] [dataset license: CC0 1.0 Universal (CC0 1.0)]

Keywords: PROTAC, CBP, p300, human cell lines, TMT11, SPS-MS3, Orbitrap Fusion, Orbitrap Lumos

Contact

Principal Investigators:
(in alphabetical order)
Christopher J. Ott, Massachusetts General Hospital Cancer Center and Harvard Medical School, United States
Submitting User: whaas

Publications

Vannam R, Sayilgan J, Ojeda S, Karakyriakou B, Hu E, Kreuzer J, Morris R, Herrera Lopez XI, Rai S, Haas W, Lawrence M, Ott CJ.
Targeted degradation of the enhancer lysine acetyltransferases CBP and p300.
Cell Chem Biol. 2021 Apr 15;28(4):503-514.e12. Epub 2021 Jan 4.

Number of Files:
Total Size:
Spectra:
Subscribers:
 
Owner Reanalyses
Experimental Design
    Conditions:
    Biological Replicates:
    Technical Replicates:
 
Identification Results
    Proteins (Human, Remapped):
    Proteins (Reported):
    Peptides:
    Variant Peptides:
    PSMs:
 
Quantification Results
    Differential Proteins:
    Quantified Proteins:
 
Browse Dataset Files
 
FTP Download Link (click to copy):

- Dataset Reanalyses


+ Dataset History


Click here to queue conversion of this dataset's submitted spectrum files to open formats (e.g. mzML). This process may take some time.

When complete, the converted files will be available in the "ccms_peak" subdirectory of the dataset's FTP space (accessible via the "FTP Download" link to the right).
Number of distinct conditions across all analyses (original submission and reanalyses) associated with this dataset.

Distinct condition labels are counted across all files submitted in the "Metadata" category having a "Condition" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct biological replicates across all analyses (original submission and reanalyses) associated with this dataset.

Distinct replicate labels are counted across all files submitted in the "Metadata" category having a "BioReplicate" or "Replicate" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct technical replicates across all analyses (original submission and reanalyses) associated with this dataset.

The technical replicate count is defined as the maximum number of times any one distinct combination of condition and biological replicate was analyzed across all files submitted in the "Metadata" category. In the case of fractionated experiments, only the first fraction is considered.

"N/A" means no results of this type were submitted.
Originally identified proteins that were automatically remapped by MassIVE to proteins in the SwissProt human reference database.

"N/A" means no results of this type were submitted.
Number of distinct protein accessions reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct unmodified peptide sequences reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct peptide sequences (including modified variants or peptidoforms) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Total number of peptide-spectrum matches (i.e. spectrum identifications) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins quantified across all analyses (original submission and reanalyses) associated with this dataset.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins found to be differentially abundant in at least one comparison across all analyses (original submission and reanalyses) associated with this dataset.

A protein is differentially abundant if its change in abundance across conditions is found to be statistically significant with an adjusted p-value <= 0.05 and lists no issues associated with statistical tests for differential abundance.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
This dataset may not contain all raw spectra data as originally deposited in PRIDE. It has been imported to MassIVE for reanalysis purposes, so its spectra data here may consist solely of processed peak lists suitable for reanalysis with most software.